(Q42523561)

1 November 2017

title

Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes (English)

1 reference

1 November 2017

M Bähr

1

1 reference

1 November 2017

M Spelleken

2

1 reference

1 November 2017

M Bock

3

1 reference

1 November 2017

M von Holtey

4

1 reference

1 November 2017

R Kiehn

5

1 reference

1 November 2017

J Eckel

6

1 reference

1 November 2017

publication date

1 July 1996

1 reference

1 November 2017

1 reference

1 November 2017

volume

39

1 reference

1 November 2017

issue

7

1 reference

1 November 2017

page(s)

766-774

1 reference

Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Antihypertensive effects of CS-045 treatment in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

In vitro studies on the action of CS-045, a new antidiabetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Pioglitazone Increases Insulin Sensitivity by Activating Insulin Receptor Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Myocardial cell dysfunction in diabetes mellitus. A review of clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Insulin action on cardiac glucose transport: studies on the role of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Induction of insulin resistance in primary cultured adult cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Insulin action on the glucose transport system in isolated cardiocytes from adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Contraction-induced translocation of the glucose transporter Glut4 in isolated ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Protein kinase C isoform expression and regulation in the developing rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Insulin and glucose modulate protein kinase C activity in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Effects of insulin and phorbol esters on subcellular distribution of protein kinase C isoforms in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050509

Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner's syndrome

21 January 2018

1 reference

12 December 2020

Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes

1 reference

12 December 2020

G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats

1 reference

12 December 2020

Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1.

1 reference

12 December 2020

Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide

1 reference

12 December 2020

Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride

1 reference

12 December 2020

Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity

1 reference

12 December 2020

Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins

1 reference

12 December 2020

Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy

1 reference

12 December 2020

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

12 December 2020

Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes.

1 reference

12 December 2020

CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes

1 reference

12 December 2020

Identifiers

DOI

10.1007/S001250050509

1 reference

1 November 2017

1 reference